Edge Therapeutics Company Profile (NASDAQ:EDGE)

About Edge Therapeutics

Edge Therapeutics logoEdge Therapeutics, Inc. is a clinical-stage biotechnology company. The Company discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions. The Company's product candidates include EG-1962 and EG-1964. The Company's lead product candidate, EG-1962, is initially being developed to improve clinical outcomes following subarachnoid hemorrhage (SAH) by administration through an external ventricular drain (EVD). Its second product candidate, EG-1964, contains aprotinin, a pancreatic trypsin inhibitor initially marketed as Trasylol, and is being developed using its Precisa development platform for the management of chronic subdural hematoma (cSDH), as a prophylactic treatment to prevent recurrent bleeding. Its product candidates utilize its Precisa development platform, which allows the Company to create therapeutics that are based on specific physical and chemical properties.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EDGE
  • CUSIP:
Key Metrics:
  • Previous Close: $10.41
  • 50 Day Moving Average: $10.03
  • 200 Day Moving Average: $9.23
  • 52-Week Range: $6.23 - $25.87
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.35
  • P/E Growth: -0.08
  • Market Cap: $300.83M
  • Outstanding Shares: 28,898,000
Profitability:
  • Return on Equity: -49.96%
  • Return on Assets: -33.94%
Debt:
  • Debt-to-Equity Ratio: 0.02%
  • Current Ratio: 16.54%
  • Quick Ratio: 16.54%
Additional Links:
Companies Related to Edge Therapeutics:

Analyst Ratings

Consensus Ratings for Edge Therapeutics (NASDAQ:EDGE) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.50 (116.14% upside)

Analysts' Ratings History for Edge Therapeutics (NASDAQ:EDGE)
Show:
DateFirmActionRatingPrice TargetDetails
5/9/2016Credit Suisse Group AGLower Price TargetOutperform$19.00 -> $18.00View Rating Details
3/11/2016Leerink SwannReiterated RatingOutperform$27.00 -> $24.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$34.00 -> $18.00View Rating Details
10/26/2015GuggenheimInitiated CoverageBuy$30.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Edge Therapeutics (NASDAQ:EDGE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/3/2016Q2($0.38)($0.33)ViewListenView Earnings Details
5/3/2016($0.34)($0.32)ViewListenView Earnings Details
3/8/2016Q4($0.32)($0.30)ViewListenView Earnings Details
11/6/2015Q315($0.23)($7.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Edge Therapeutics (NASDAQ:EDGE)
Current Year EPS Consensus Estimate: $-1.43 EPS
Next Year EPS Consensus Estimate: $-1.64 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.42)($0.42)($0.42)
Q2 20161($0.43)($0.43)($0.43)
Q3 20161($0.38)($0.38)($0.38)
Q4 20161($0.41)($0.41)($0.41)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Edge Therapeutics (NASDAQ:EDGE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Edge Therapeutics (NASDAQ:EDGE)
Insider Ownership Percentage: 44.29%
Institutional Ownership Percentage: 47.94%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2016W Bradford MiddlekauffVPBuy10,000$9.48$94,800.00View SEC Filing  
8/1/2016Brian A LeuthnerInsiderSell7,500$9.54$71,550.00View SEC Filing  
3/11/2016James HealyDirectorBuy541,343$7.30$3,951,803.90View SEC Filing  
10/6/2015Andrew J. EinhornCFOBuy45,000$11.00$495,000.00View SEC Filing  
10/6/2015James HealyDirectorBuy450,000$11.00$4,950,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Edge Therapeutics (NASDAQ:EDGE)
DateHeadline
News IconThe first report delivered on Sage Therapeutics, Inc. - 2016 Product Pipeline ... (NASDAQ:EDGE)
www.medgadget.com - September 30 at 9:50 AM
News IconWhat Analysts are saying about? Deutsche Bank AG (NYSE:DB) , Edge Therapeutics, Inc. (NASDAQ:EDGE) - Wall Street Times (press release) (NASDAQ:EDGE)
www.wallstreetnews24.com - September 29 at 4:43 PM
News IconBroker Roundup For Edge Therapeutics, Inc. (NASDAQ:EDGE) - The De Soto Edge (NASDAQ:EDGE)
desotoedge.com - September 29 at 4:43 PM
News IconFive Prime Therapeutics, Inc. (NASDAQ:FPRX) Updated Broker Price Targets (NASDAQ:EDGE)
desotoedge.com - September 29 at 9:46 AM
News IconNew Analyst Ratings On Edge Therapeutics, Inc. (NASDAQ:EDGE) - NewsDen (NASDAQ:EDGE)
newsden.net - September 28 at 4:38 PM
News IconFortis Therapeutics Closes $18 Million Series A Financing to Advance New Antibody Drug Conjugate Therapies for the Treatment of Late-Stage Cancers (NASDAQ:EDGE)
www.medindia.net - September 27 at 9:22 AM
News IconMover to Watch: Edge Therapeutics, Inc. (NASDAQ:EDGE) , Pacific DataVision, Inc. (NASDAQ:PDVW) - Wall Street Times (press release) (NASDAQ:EDGE)
www.wallstreetnews24.com - September 21 at 5:18 PM
News IconEdge Therapeutics Incorporated (NASDAQ:EDGE) Short Interest Increased By 1.71% - Post News (NASDAQ:EDGE)
www.kentuckypostnews.com - September 19 at 3:38 PM
4-traders.com logoEdge Therapeutics : Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc. (NASDAQ:EDGE)
www.4-traders.com - September 16 at 4:38 PM
finance.yahoo.com logoEmber Therapeutics Acquires Dermasilk™ Brands (NASDAQ:EDGE)
finance.yahoo.com - September 12 at 4:35 PM
News IconSizzling Stocks Alerts - Exar Corporation (NYSE:EXAR) , Edge Therapeutics, Inc. (NASDAQ:EDGE) - Wall Street Times (press release) (NASDAQ:EDGE)
www.wallstreetnews24.com - September 12 at 9:39 AM
globenewswire.com logoEdge Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series and ... - GlobeNewswire (press release) (NASDAQ:EDGE)
globenewswire.com - September 10 at 4:29 PM
News IconEdge Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series and Participate in Additional Investor… (NASDAQ:EDGE)
forextv.com - September 8 at 4:40 PM
News IconEdge Therapeutics Announces Additional Pharmacokinetic Data Supporting The Potential Clinical And Health ... - Clinical Leader (NASDAQ:EDGE)
www.clinicalleader.com - September 8 at 8:35 AM
News IconEdge Therapeutics to Present at the Leerink Partners Rare Disease Immuno-Oncology Roundtable Series and ... - EconoTimes (NASDAQ:EDGE)
www.econotimes.com - September 8 at 8:35 AM
publicnow.com logoEdge Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series and Participate in Additional Investor Conferences in September (NASDAQ:EDGE)
www.publicnow.com - September 8 at 8:35 AM
News IconEdge Therapeutics Announces Additional Pharmacokinetic Data ... - EconoTimes (NASDAQ:EDGE)
www.econotimes.com - September 7 at 8:03 AM
publicnow.com logoEdge Therapeutics Announces Additional Pharmacokinetic Data Supporting the Potential Clinical and Health Economic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage (NASDAQ:EDGE)
www.publicnow.com - September 6 at 4:39 PM
proactiveinvestors.co.uk logoHorizon Discovery inks new collaboration (NASDAQ:EDGE)
www.proactiveinvestors.co.uk - September 6 at 9:37 AM
investingnews.com logo5 Top NASDAQ Biotech Stocks: Cynapsus Therapeutics Soars on Acquisition - Investing News Network (press release) (registration) (blog) (NASDAQ:EDGE)
investingnews.com - September 5 at 4:28 PM
prnewswire.com logoCynata and FUJIFILM Sign Non-binding Development and Commercialisation Term Sheet - PR Newswire (press release) (NASDAQ:EDGE)
www.prnewswire.com - September 5 at 4:28 PM
News IconStock Struggling for the Quarter: Edge Therapeutics, Inc. (:EDGE) - Post News (NASDAQ:EDGE)
www.kentuckypostnews.com - September 4 at 9:14 AM
News IconKaryopharm Therapeutics Inc. (NASDAQ: KPTI) Puts Investors On The Edge - Scibility Media (NASDAQ:EDGE)
scibilitymedia.com - September 2 at 4:41 PM
finance.yahoo.com logoEdge Therapeutics to Present Additional Data from Phase 1/2 NEWTON Study of EG-1962 at Two Scientific Conferences in September (NASDAQ:EDGE)
finance.yahoo.com - September 1 at 4:41 PM
4-traders.com logoTrillium Therapeutics : Introduces Industry Postdoctoral Fellowship Program (NASDAQ:EDGE)
www.4-traders.com - August 30 at 4:49 PM
News IconBiotech one step closer to bowel disease treatment (NASDAQ:EDGE)
scienceblog.com - August 22 at 4:49 PM
News IconThe Green Rush: Searching for (High) Yields (NASDAQ:EDGE)
wire.kapitall.com - August 22 at 4:49 PM
globenewswire.com logoEdge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock ... - GlobeNewswire (press release) (NASDAQ:EDGE)
globenewswire.com - August 20 at 8:12 AM
einnews.com logoEdge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock Market Closing Bell - EIN News (press release) (NASDAQ:EDGE)
www.einnews.com - August 19 at 3:52 PM
publicnow.com logoEdge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:EDGE)
www.publicnow.com - August 19 at 3:52 PM
News IconDigital therapeutics market worth 457.9 million USD by 2021 according to new research report (NASDAQ:EDGE)
www.whatech.com - August 19 at 7:44 AM
News IconShares Moving Lower Over the Past Month Edge Therapeutics, Inc. (:EDGE) - Post News (NASDAQ:EDGE)
www.kentuckypostnews.com - August 18 at 7:26 AM
finance.yahoo.com logoEDGE THERAPEUTICS, INC. Financials (NASDAQ:EDGE)
finance.yahoo.com - August 11 at 4:55 PM
fidaily.com logoEdge Therapeutics, Inc. (NASDAQ:EDGE) Trading Unchanged - Insider Trading Activity - Finance Daily (NASDAQ:EDGE)
www.fidaily.com - August 9 at 8:59 PM
twst.com logoEdge Therapeutics Inc.: Edge Therapeutics Reports Second Quarter Financial Results and Recent Highlights (NASDAQ:EDGE)
www.twst.com - August 4 at 4:58 PM
finance.yahoo.com logoEdited Transcript of EDGE earnings conference call or presentation 3-Aug-16 12:30pm GMT (NASDAQ:EDGE)
finance.yahoo.com - August 4 at 7:53 AM
reuters.com logoBRIEF-Edge Therapeutics reports Q2 loss per share $0.33 - Reuters (NASDAQ:EDGE)
www.reuters.com - August 3 at 10:24 PM
seekingalpha.com logoEdge Therapeutics' (EDGE) CEO Brian Leuthner on Q2 2016 ... - Seeking Alpha (NASDAQ:EDGE)
seekingalpha.com - August 3 at 10:24 PM
biz.yahoo.com logoEdge Therapeutics Inc Earnings Call (Q2 2016) (NASDAQ:EDGE)
biz.yahoo.com - August 3 at 4:54 PM
seekingalpha.com logoEdge Therapeutics' (EDGE) CEO Brian Leuthner on Q2 2016 Results - Earnings Call Transcript (NASDAQ:EDGE)
seekingalpha.com - August 3 at 4:54 PM
finance.yahoo.com logoEdge Therapeutics Reports Second Quarter Financial Results and Recent Highlights (NASDAQ:EDGE)
finance.yahoo.com - August 3 at 4:54 PM
biz.yahoo.com logoEDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (NASDAQ:EDGE)
biz.yahoo.com - August 3 at 4:54 PM
globenewswire.com logoEdge Therapeutics Reports Second Quarter Financial Results and Recent Highlights - GlobeNewswire (press release) (NASDAQ:EDGE)
globenewswire.com - August 3 at 7:35 AM
sg.finance.yahoo.com logoEdge Therapeutics reports 2Q loss (NASDAQ:EDGE)
sg.finance.yahoo.com - August 3 at 7:35 AM
biz.yahoo.com logoQ2 2016 Edge Therapeutics Inc Earnings Release - Before Market Open (NASDAQ:EDGE)
biz.yahoo.com - August 3 at 7:35 AM
biz.yahoo.com logoEdge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:EDGE)
biz.yahoo.com - August 3 at 7:35 AM
biz.yahoo.com logoEDGE THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia (NASDAQ:EDGE)
biz.yahoo.com - August 2 at 4:55 PM
reuters.com logoBRIEF-Edge Therapeutics says closing a dual-tranche term loan with Hercules Capital - Reuters (NASDAQ:EDGE)
www.reuters.com - August 2 at 9:34 AM
globenewswire.com logoEdge Therapeutics Announces Closing of $20 Million Debt Facility ... - GlobeNewswire (press release) (NASDAQ:EDGE)
globenewswire.com - August 2 at 9:34 AM
finance.yahoo.com logo6:36 am Edge Therapeutics closes a $20 million dual-tranche term loan (NASDAQ:EDGE)
finance.yahoo.com - August 2 at 9:34 AM

Social

Edge Therapeutics (NASDAQ:EDGE) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff